The AML1-ETO9a oncogenic transcript is expressed in a majority of t(8;21) AML patients studied and encodes a truncated AML1-ETO protein with enhanced leukemogenic potential [46,47]. Here, RUNX1 is linked to acute myeloid leukemia.